SAN DIEGO, Sept. 12, 2016 /PRNewswire/ --
Shareholder rights law firm Johnson & Weaver, LLP has
launched an investigation into whether the board members of Raptor
Pharmaceutical Corp. (NASDAQ:RPTP) breached their fiduciary duties
in connection with the proposed sale of the Company to Horizon
Pharma Plc.
Additional Information:
Raptor is a biopharmaceutical company that focuses on developing
and commercializing transformative treatments for people affected
by rare and debilitating diseases.
On September 12, 2016, Raptor
announced it had signed a definitive merger agreement with
Horizon. Under the terms of the agreement, Horizon will pay
$9.00 per share in cash for each
share of Raptor common stock.
The investigation concerns whether the Raptor board failed to
satisfy their duties to the Company shareholders, including whether
the board adequately pursued alternatives to the acquisition and
whether the board obtained the best price possible for Raptor
shares of common stock. Nationally recognized Johnson & Weaver
is investigating whether the proposed deal price represents
adequate consideration. The deal may undervalue the Company
resulting in a loss for many long term shareholders. For example,
in July 2015, Raptor traded at over
$15.00.
If you are a shareholder of Raptor and believe the
proposed buyout price is too low and you're interested in learning
more about the investigation or your legal rights and remedies,
please contact lead analyst Jim
Baker (jimb@johnsonandweaver.com) at 619-814-4471.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder
rights law firm with offices in California, New
York and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonandweaver.com. Attorney advertising. Past results
do not guarantee future outcomes.
Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com
Logo - http://photos.prnewswire.com/prnh/20160211/332409LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/raptor-rptp-alert-johnson--weaver-llp-launches-an-investigation-into-the-fairness-of-price-and-process-in-proposed-sale-of-raptor-pharmaceutical-corp-are-shareholders-getting-a-fair-price-300326124.html
SOURCE Johnson & Weaver, LLP